AMCR vs LMAT · P/E 18, rev $23.51B vs P/E 35, rev $136.9M
Amcor PLC (AMCR) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported LMAT revenue for 2026-06-30 was $136.9M. Net income was $32.7M. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the AMCR and LMAT stock pages for the full models.
Not investment advice.